MetLife Investment Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,622,910
-20.5%
32,3160.0%0.01%
-13.3%
Q2 2023$2,042,371
+42.8%
32,316
+1.7%
0.02%
+36.4%
Q1 2023$1,429,872
+2.7%
31,7820.0%0.01%0.0%
Q4 2022$1,392,369
-33.5%
31,7820.0%0.01%
-38.9%
Q3 2022$2,094,116
+30.4%
31,7820.0%0.02%
+38.5%
Q2 2022$1,605,309
-20.9%
31,7820.0%0.01%0.0%
Q1 2022$2,030,234
-8.2%
31,782
+53.9%
0.01%
-31.6%
Q4 2021$2,211,929
+4.2%
20,6510.0%0.02%
-5.0%
Q3 2021$2,123,129
+16.9%
20,6510.0%0.02%
+17.6%
Q2 2021$1,816,462
-9.5%
20,6510.0%0.02%
-10.5%
Q1 2021$2,007,897
-18.0%
20,651
-5.4%
0.02%
-24.0%
Q4 2020$2,448,683
+10.6%
21,834
-8.6%
0.02%
+4.2%
Q3 2020$2,213,491
+18.8%
23,8780.0%0.02%
+14.3%
Q2 2020$1,862,484
+41.5%
23,878
+6.1%
0.02%
+10.5%
Q1 2020$1,316,092
-19.9%
22,505
+9.7%
0.02%
+11.8%
Q4 2019$1,643,537
+2.8%
20,516
-5.8%
0.02%
-5.6%
Q3 2019$1,599,515
-22.1%
21,7710.0%0.02%
-21.7%
Q2 2019$2,053,654
+44.1%
21,771
+22.3%
0.02%
+43.8%
Q1 2019$1,425,370
+48.5%
17,8060.0%0.02%
+33.3%
Q4 2018$959,921
-30.9%
17,8060.0%0.01%
-20.0%
Q3 2018$1,389,936
+13.1%
17,806
-8.1%
0.02%0.0%
Q2 2018$1,229,000
-30.8%
19,3680.0%0.02%
-28.6%
Q1 2018$1,776,000
+21.6%
19,3680.0%0.02%
+23.5%
Q4 2017$1,461,00019,3680.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2020
NameSharesValueWeighting ↓
Boxer Capital, LLC 705,159$12,728,00012.46%
BVF INC/IL 2,640,251$47,657,00011.79%
Casdin Capital, LLC 321,300$5,799,0006.66%
Opaleye Management Inc. 220,000$3,971,0002.48%
PFM Health Sciences, LP 1,420,511$25,640,0000.79%
Perceptive Advisors 404,404$7,299,0000.64%
Partner Investment Management, L.P. 18,788$339,0000.55%
Visium Asset Management, LP 1,265,025$22,834,0000.39%
DRIEHAUS CAPITAL MANAGEMENT LLC 661,717$11,944,0000.39%
Virtus ETF Advisers LLC 10,484$189,0000.26%
View complete list of BLUEPRINT MEDICINES CORP shareholders